Millennium Management LLC Acquires 361,263 Shares of Humana Inc (HUM)

Millennium Management LLC grew its holdings in Humana Inc (NYSE:HUM) by 254.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 503,066 shares of the insurance provider’s stock after purchasing an additional 361,263 shares during the quarter. Millennium Management LLC owned approximately 0.37% of Humana worth $144,118,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Moody National Bank Trust Division bought a new position in shares of Humana in the 4th quarter valued at about $30,000. Proficio Capital Partners LLC boosted its stake in Humana by 81.4% during the 4th quarter. Proficio Capital Partners LLC now owns 107 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 48 shares during the last quarter. We Are One Seven LLC bought a new position in Humana during the 4th quarter worth approximately $31,000. Exane Asset Management bought a new position in Humana during the 4th quarter worth approximately $43,000. Finally, Sontag Advisory LLC bought a new position in Humana during the 4th quarter worth approximately $47,000. 94.51% of the stock is currently owned by institutional investors.

HUM stock traded down $5.35 during mid-day trading on Monday, hitting $267.25. 21,562 shares of the company were exchanged, compared to its average volume of 1,255,626. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.68 and a current ratio of 1.68. The company has a market capitalization of $36.97 billion, a P/E ratio of 18.37, a price-to-earnings-growth ratio of 1.12 and a beta of 0.94. Humana Inc has a 1-year low of $261.35 and a 1-year high of $355.88.



Humana (NYSE:HUM) last announced its earnings results on Wednesday, February 6th. The insurance provider reported $2.65 EPS for the quarter, topping the consensus estimate of $2.53 by $0.12. The firm had revenue of $14.17 billion for the quarter, compared to the consensus estimate of $14.04 billion. Humana had a net margin of 2.96% and a return on equity of 19.64%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period last year, the company posted $2.06 EPS. Analysts forecast that Humana Inc will post 17.49 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Shareholders of record on Friday, March 29th will be issued a dividend of $0.55 per share. This is an increase from Humana’s previous quarterly dividend of $0.50. This represents a $2.20 annualized dividend and a yield of 0.82%. The ex-dividend date of this dividend is Thursday, March 28th. Humana’s dividend payout ratio (DPR) is 6.87%.

Several research firms recently weighed in on HUM. Credit Suisse Group reduced their price objective on shares of Humana from $390.00 to $352.00 and set an “outperform” rating on the stock in a research note on Thursday, February 7th. Stephens began coverage on shares of Humana in a research note on Monday, January 14th. They set an “overweight” rating and a $336.00 price objective on the stock. Zacks Investment Research lowered shares of Humana from a “buy” rating to a “hold” rating in a research note on Friday, February 8th. Cowen raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $275.02 price objective on the stock in a research note on Friday, January 11th. Finally, Cantor Fitzgerald reissued a “hold” rating and set a $325.00 price objective on shares of Humana in a research note on Wednesday, January 2nd. Five equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $355.06.

In other Humana news, insider Christopher H. Hunter sold 15,586 shares of the firm’s stock in a transaction that occurred on Monday, February 25th. The shares were sold at an average price of $305.24, for a total transaction of $4,757,470.64. Following the sale, the insider now directly owns 28,100 shares in the company, valued at approximately $8,577,244. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Roy A. Beveridge sold 8,278 shares of the firm’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $307.16, for a total transaction of $2,542,670.48. Following the sale, the insider now owns 12,409 shares in the company, valued at $3,811,548.44. The disclosure for this sale can be found here. Company insiders own 0.54% of the company’s stock.

WARNING: This article was published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://dakotafinancialnews.com/2019/03/25/millennium-management-llc-acquires-361263-shares-of-humana-inc-hum.html.

Humana Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

See Also: What are the FAANG Stocks?

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.